We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$968M
AUM Growth
-$68.3M
Cap. Flow
-$96.6M
Cap. Flow %
-9.98%
Top 10 Hldgs %
20.08%
Holding
400
New
23
Increased
126
Reduced
199
Closed
15

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$4.79M
2
HPE icon
Hewlett Packard
HPE
+$3.69M
3
DHR icon
Danaher
DHR
+$2.16M
4
TXT icon
Textron
TXT
+$2.1M
5
EXC icon
Exelon
EXC
+$1.72M

Sector Composition

Rank Sector Weight
1 Healthcare 15.52%
2 Financials 15.22%
3 Technology 14.92%
4 Industrials 9.38%
5 Consumer Staples 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMJ
1
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$36.1M 3.73%
1,146,295
-25,531
-2% -$803K
AAPL icon
2
Apple
AAPL
$4.76T
$24.8M 2.56%
877,324
+32,120
+4% +$850K
JNJ icon
3
Johnson & Johnson
JNJ
$613B
$20M 2.07%
169,492
-1,439
-0.8% -$175K
CMCSA icon
4
Comcast
CMCSA
$84.4B
$18.9M 1.95%
570,104
+10,688
+2% +$356K
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.06T
$18.7M 1.94%
129,710
+9,875
+8% +$1.44M
INTC icon
6
Intel
INTC
$522B
$16.7M 1.72%
441,148
-3,797
-0.9% -$134K
PFE icon
7
Pfizer
PFE
$142B
$15.8M 1.64%
492,886
-1,182
-0.2% -$39.5K
XOM icon
8
ExxonMobil
XOM
$639B
$15.7M 1.62%
180,064
+124
+0.1% +$11K
AET
9
DELISTED
Aetna Inc
AET
$13.8M 1.43%
119,812
+52
+0% +$6.09K
CVS icon
10
CVS Health
CVS
$140B
$13.7M 1.42%
154,423
-2,755
-2% -$260K
MSFT icon
11
Microsoft
MSFT
$2.88T
$13.4M 1.38%
231,947
-11,493
-5% -$649K
NOC icon
12
Northrop Grumman
NOC
$75.3B
$13.2M 1.37%
61,901
-4,908
-7% -$1.06M
UNH icon
13
UnitedHealth
UNH
$395B
$12.3M 1.28%
88,191
-5,269
-6% -$738K
TSN icon
14
Tyson Foods
TSN
$20.1B
$11.8M 1.22%
158,344
+65,346
+70% +$4.79M
IWC icon
15
iShares Micro-Cap ETF
IWC
$1.46B
$11.8M 1.22%
150,827
-976
-0.6% -$73.3K
CVX icon
16
Chevron
CVX
$384B
$11.3M 1.17%
109,989
-4,051
-4% -$414K
T icon
17
AT&T
T
$159B
$11.2M 1.16%
366,001
+35,696
+11% +$1.13M
AMGN icon
18
Amgen
AMGN
$198B
$11.2M 1.16%
67,266
+2,195
+3% +$371K
DIS icon
19
Walt Disney
DIS
$167B
$10.9M 1.12%
116,923
-341
-0.3% -$32.7K
TWX
20
DELISTED
Time Warner Inc
TWX
$10.7M 1.11%
134,794
-395
-0.3% -$30.9K
TMO icon
21
Thermo Fisher Scientific
TMO
$195B
$10.7M 1.1%
67,101
-3,859
-5% -$595K
IBM icon
22
IBM
IBM
$193B
$10.4M 1.07%
68,198
+1,429
+2% +$217K
TRV icon
23
Travelers Companies
TRV
$82.1B
$9.95M 1.03%
86,834
+2,604
+3% +$305K
CSCO icon
24
Cisco
CSCO
$444B
$9.92M 1.02%
312,644
+9,437
+3% +$290K
ED icon
25
Consolidated Edison
ED
$41.2B
$9.59M 0.99%
127,405
-4,161
-3% -$323K

Similar funds

RegentAtlantic Capital's Q3 2016 Portfolio in Review

As of Q3 2016, RegentAtlantic Capital held 400 positions worth $968M, down 6.6% from $1.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

RegentAtlantic Capital withdrew a net $96.6M in Q3 2016, closing 15 positions and reducing 199 holdings. Its most notable exit was State Street SPDR EURO STOXX 50 ETF, an estimated $3.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

Against the trend, RegentAtlantic Capital opened a new position in Vanguard S&P 500 ETF worth $1.05M.

  • RegentAtlantic Capital's largest Q3 2016 buy was Vanguard S&P 500 ETF: 5,267 shares worth $1.05M.
  • RegentAtlantic Capital added most to Tyson Foods in Q3 2016, an estimated $4.79M increase.
  • RegentAtlantic Capital's biggest Q3 2016 reduction was iShare MSCI Eurozone ETF, cutting an estimated $98.6M.
  • RegentAtlantic Capital fully exited State Street SPDR EURO STOXX 50 ETF in Q3 2016, selling an estimated $3.92M.
  • RegentAtlantic Capital's ten largest holdings make up 20% of its $968M portfolio in Q3 2016.
  • RegentAtlantic Capital opened 23 new positions and closed 15 in Q3 2016.
  • RegentAtlantic Capital's portfolio value fell 6.6% quarter-over-quarter to $968M.

Based on RegentAtlantic Capital's 13F filing for Q3 2016, filed 24 Oct 2016.